Champions Oncology (CSBR) EBITDA Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | -101.00 |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | -38.00 |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 224.00 |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | -463.00 |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 4,868.00 |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | -14,185.00 |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 1,247.00 |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | -5,330.00 |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | -744,940.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 1,247.00 |
| Jan 31, 2026 | -2,807.00 |
| Oct 31, 2025 | -420.00 |
| Jul 31, 2025 | -1,322.00 |
| Apr 30, 2025 | -1,431.00 |
| Jan 31, 2025 | 4,785.00 |
| Oct 31, 2024 | 2,232.00 |
| Jul 31, 2024 | 2,977.00 |
| Apr 30, 2024 | 1,735.00 |
| Jan 31, 2024 | -220.00 |
| Oct 31, 2023 | -1,694.00 |
| Jul 31, 2023 | -1,825.00 |
| Apr 30, 2023 | -1,687.00 |
| Jan 31, 2023 | -2,553.00 |
| Oct 31, 2022 | -218.00 |
| Jul 31, 2022 | -51.00 |
| Apr 30, 2022 | 372.00 |
| Jan 31, 2022 | -279.00 |
| Oct 31, 2021 | 216.00 |
| Jul 31, 2021 | -181.00 |